Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1758
ALMS
Alumis Inc. - Common Stock
21.81 USD-2.55%-7.27%-21.24%+383.59%2.82 B USD
1785
ATAI
AtaiBeckley Inc. - Common Stock
7.34 USD+0.69%-0.54%+2.23%+85.82%2.72 B USD
1796
NRIX
Nurix Therapeutics, Inc. - Common stock
25.78 USD-1.64%-3.52%+12.28%+129.97%2.68 B USD
1814
VRDN
Viridian Therapeutics, Inc. - Common Stock
23.16 USD+0.35%-3.82%+23.19%+3.16%2.62 B USD

Frequently asked questions about SELLAS Life Sciences Group, Inc. Common Stock

What is the SELLAS Life Sciences Group, Inc. Common Stock stock price today?

The current price of SELLAS Life Sciences Group, Inc. Common Stock (SLS) is 13.34. Over the past 24 hours, the stock has changed by +0.98%. Follow the SLS chart for real-time price dynamics.

What is the stock ticker of SELLAS Life Sciences Group, Inc. Common Stock?

SELLAS Life Sciences Group, Inc. Common Stock trades under the ticker SLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is SELLAS Life Sciences Group, Inc. Common Stock stock going up?

SLS has changed by -8.38% over the last week, +33.40% over the last month, and +594.79% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of SELLAS Life Sciences Group, Inc. Common Stock?

SELLAS Life Sciences Group, Inc. Common Stock currently has a market capitalization of 2.69 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does SELLAS Life Sciences Group, Inc. Common Stock release financial reports?

Yes. You can track SELLAS Life Sciences Group, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were SELLAS Life Sciences Group, Inc. Common Stock earnings last quarter?

Last quarter, SELLAS Life Sciences Group, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was SELLAS Life Sciences Group, Inc. Common Stock net income for the last quarter?

SELLAS Life Sciences Group, Inc. Common Stock reported net income of -9.61 M for the last quarter. The previous quarter showed -8.41 M, which means net income changed by -14.25%.

How many employees does SELLAS Life Sciences Group, Inc. Common Stock have?

As of the latest available data, SELLAS Life Sciences Group, Inc. Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy SELLAS Life Sciences Group, Inc. Common Stock stock?

You can buy SELLAS Life Sciences Group, Inc. Common Stock (SLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in SELLAS Life Sciences Group, Inc. Common Stock stock?

Investing in SELLAS Life Sciences Group, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLS chart and related analysis on metatrader.com as part of your research.

News